# K110003: MTF New Bone Void Filler

- Pathway: 510(k) (Traditional)
- Applicant: Musculoskeletal Transplant Foundation
- Decided: Oct 13, 2011 after 283 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K042829 (2006). 4 ancestors in all.
3 later devices descend from it; 2 cite it directly.
0 of 8 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K080399: DBX Demineralized Bone Matrix Putty, DBX Demineralized Bone Matrix Paste, Musculoskeletal Transplant Foundation (2008) Summary page 1.
- K042829: DBX Strip, Musculoskeletal Transplant Foundation (2006) Summary page 1.
- K062205: DBX Strip, Musculoskeletal Transplant Foundation (2007) Summary page 1.

## Most influential descendants
- K121989: Optecure Bone Void Filler (0.5 CC, 1CC, 2CC, 5CC, 10CC, and 20CC), Optecure + CCC Bone Void Filler (1CC, 2CC, 5CC, 10CC, (2012), 1 descendant of its own
- K241555: Moldable Bone Void Filler and Moldable Bone Void Filler + CCC (2025), 0 descendants of its own
- K121313: MTF New Bone Void Filler (2013), 0 descendants of its own

## Indications for use
The MTF New Bone Void Filler is intended for use as a Demineralized Bone Matrix for voids or gaps that are not intrinsic to the stability of the bony structure. The MTF New Bone Void Filler is indicated for treatment of surgically created osseous defects or osseous defects created from traumatic injury. It is for use in the posterolateral spine only, for posterolateral spine fusions. The MTF New Bone Void Filler must be used in the spine with bone marrow aspirate. The MTF New Bone Void Filler is for single patient use only.

Source page: https://510kreport.com/device/K110003
Methodology: https://510kreport.com/methodology